303 related articles for article (PubMed ID: 11336565)
1. Intelligent use of NSAIDs--where do we stand?
Berger RG
Expert Opin Pharmacother; 2001 Jan; 2(1):19-30. PubMed ID: 11336565
[TBL] [Abstract][Full Text] [Related]
2. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
3. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
[TBL] [Abstract][Full Text] [Related]
6. "Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.
Bennett K; Teeling M; Feely J
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):645-9. PubMed ID: 12942226
[TBL] [Abstract][Full Text] [Related]
7. Is there a place for non-selective NSAIDs in the treatment of arthritis?
Crofford LJ
Joint Bone Spine; 2002 Jan; 69(1):4-7. PubMed ID: 11858355
[No Abstract] [Full Text] [Related]
8. Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly.
Bell GM; Schnitzer TJ
Clin Geriatr Med; 2001 Aug; 17(3):489-502, vi. PubMed ID: 11459717
[TBL] [Abstract][Full Text] [Related]
9. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
10. Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy.
Fendrick AM
Cleve Clin J Med; 2002; 69 Suppl 1():SI59-64. PubMed ID: 12086296
[TBL] [Abstract][Full Text] [Related]
11. COX-2-Selective NSAIDs: new and improved?
Lichtenstein DR; Wolfe MM
JAMA; 2000 Sep; 284(10):1297-9. PubMed ID: 10980759
[No Abstract] [Full Text] [Related]
12. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.
Daoud KF; Jackson CG; Williams HJ
Compr Ther; 1999; 25(8-10):427-33. PubMed ID: 10520445
[TBL] [Abstract][Full Text] [Related]
13. COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL; Cryer B
JAMA; 1999 Nov; 282(20):1961-3. PubMed ID: 10580464
[No Abstract] [Full Text] [Related]
14. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
15. COX-2--selective NSAIDs.
Hutchison R
Am J Nurs; 2004 Mar; 104(3):52-5; quiz 55-6. PubMed ID: 15108571
[No Abstract] [Full Text] [Related]
16. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
Savage R
Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652
[TBL] [Abstract][Full Text] [Related]
17. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.
Marshall JK; Pellissier JM; Attard CL; Kong SX; Marentette MA
Pharmacoeconomics; 2001; 19(10):1039-49. PubMed ID: 11735672
[TBL] [Abstract][Full Text] [Related]
18. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of COX-2 inhibitors in arthritis.
Jackson CG
Expert Opin Investig Drugs; 2001 Jul; 10(7):1317-25. PubMed ID: 11772254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
